Resumo

VILAR, Fernando Crivelenti et al. Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin. Rev. Soc. Bras. Med. Trop. [online]. 2007, vol.40, n.6, pp. 678-680. ISSN 0037-8682.  http://dx.doi.org/10.1590/S0037-86822007000600016.

Two cases of autoimmune hemolytic anemia that occurred during the treatment of chronic hepatitis C with pegylated alpha-2a interferon and ribavirin, in HIV coinfected patients, are presented and described. The late occurrence (after six months of therapy) of this severe hemolytic anemia leads to the recommendation that hemoglobin levels should be monitored throughout the treatment period, even among patients who presented stable hemoglobin levels in the preceding months.

Palavras-chave : Hemolytic anemia; Treatment; Hepatitis C; Pegylated alpha-2a interferon; HIV/AIDS.